A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Status:
Active, not recruiting

Trial end date:
2021-05-25

Target enrollment:

Participant gender:

This study will be conducted as a multi-center, open label study in the US. There will be 40 patient to receive the active investigational product.

Phase 1

Enterin Inc.